“As a leading tumor specimen provider, Bio-Options required an accurate solution for classifying tumors. Classifying tumors is a tedious, time-consuming process that ties up our highly trained professionals.
We tried mainstream AI models like GPT and Gemini but they fell short and privacy is critical. This is where InteliGems Labs stepped in. Their Launchpad process and AI models quickly advanced us from concept to a pilot customized to our needs.
The results are amazing: $400,000 in annual savings, 80% faster order fulfillment, and a 20% increase in orders. We're excited to explore further AI innovations with InteliGems; they’re an exceptional AI partner.”
Larry Blocher, M.D., J.D.
CEO, Bio-Options
.png)








.svg.png)







.png)